Clinical Trial Update: Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the efficacy and safety of lobaplatin and carboplatin as neoadjuvant therapy for HER-2 positive breast cancer; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Lobaplatin (lobaplatin)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Breast Cancer | Phase 4 | Status: NOT_YET_RECRUITING